Holders — by stockHoldings — by fund
Integral Health Asset Management, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001773206
$2.53B
disclosed book value
90
positions
11.1%
largest position share
Positions, as of 2026-06-30
top 92 of 90 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | RVMDREVOLUTION MEDICINES INC | 1.5M | $280.9M | 11.1% |
| 2 | INSMINSMED INC | 1.6M | $170.6M | 6.7% |
| 3 | CYTKCYTOKINETICS INC | 1.6M | $136.3M | 5.4% |
| 4 | CVSCVS HEALTH CORP | 1.1M | $113.8M | 4.5% |
| 5 | EWTXEDGEWISE THERAPEUTICS INC | 2.0M | $81.3M | 3.2% |
| 6 | VERAVERA THERAPEUTICS INC | 1.8M | $75.1M | 3% |
| 7 | AXSMAXSOME THERAPEUTICS INC. | 300,000 | $73.4M | 2.9% |
| 8 | CAHCARDINAL HEALTH INC | 300,000 | $71.3M | 2.8% |
| 9 | ROIVANT SCIENCES LTD | 2.0M | $70.8M | 2.8% |
| 10 | RYTMRHYTHM PHARMACEUTICALS INC | 550,000 | $61.1M | 2.4% |
| 11 | EWEDWARDS LIFESCIENCES CORP | 625,000 | $56.5M | 2.2% |
| 12 | RVMDREVOLUTION MEDICINES INCPUT | 300,000 | $56.2M | 2.2% |
| 13 | ALHCALIGNMENT HEALTHCARE INC | 2.0M | $47.6M | 1.9% |
| 14 | MRKMERCK & CO INC | 350,000 | $45.0M | 1.8% |
| 15 | DGXQUEST DIAGNOSTICS INC | 200,000 | $42.4M | 1.7% |
| 16 | UNIQURE NV | 900,000 | $41.5M | 1.6% |
| 17 | SRRKSCHOLAR ROCK HLDG CORP | 750,000 | $41.3M | 1.6% |
| 18 | BSXBOSTON SCIENTIFIC CORP | 900,000 | $38.4M | 1.5% |
| 19 | BTSGBRIGHTSPRING HEALTH SVCS INC | 550,000 | $38.4M | 1.5% |
| 20 | ABTABBOTT LABORATORIES | 400,000 | $36.3M | 1.4% |
| 21 | UNHUNITEDHEALTH GROUP INC | 85,000 | $35.3M | 1.4% |
| 22 | LFSTLIFESTANCE HEALTH GROUP INC | 3.0M | $32.1M | 1.3% |
| 23 | NVSNOVARTIS AG | 200,000 | $31.3M | 1.2% |
| 24 | TNGXTANGO THERAPEUTICS INC | 1.0M | $31.3M | 1.2% |
| 25 | THCTENET HEALTHCARE CORP | 165,000 | $30.9M | 1.2% |
| 26 | SYRESPYRE THERAPEUTICS INC | 325,000 | $28.9M | 1.1% |
| 27 | NVONOVO-NORDISK A S | 600,000 | $28.8M | 1.1% |
| 28 | DFTXDEFINIUM THERAPEUTICS INC | 550,000 | $25.9M | 1% |
| 29 | NBIXNEUROCRINE BIOSCIENCES INC | 150,000 | $25.3M | 1% |
| 30 | REGNREGENERON PHARMACEUTICALS | 40,000 | $24.9M | 1% |
| 31 | IONSIONIS PHARMACEUTICALS INCCALL | 300,000 | $23.8M | 0.9% |
| 32 | BIIBBIOGEN INC | 100,000 | $21.6M | 0.9% |
| 33 | TVTXTRAVERE THERAPEUTICS INC | 375,000 | $21.3M | 0.8% |
| 34 | LNTHLANTHEUS HLDGS INC | 190,000 | $21.1M | 0.8% |
| 35 | GKOSGLAUKOS CORP | 150,000 | $21.0M | 0.8% |
| 36 | ORICORIC PHARMACEUTICALS INC | 1.9M | $20.6M | 0.8% |
| 37 | BBIOBRIDGEBIO PHARMA INC | 275,000 | $20.5M | 0.8% |
| 38 | VRTXVERTEX PHARMACEUTICALS INC | 40,000 | $19.9M | 0.8% |
| 39 | ALMSALUMIS INC | 700,000 | $19.7M | 0.8% |
| 40 | ELVELEVANCE HEALTH INC FORMERLY | 50,000 | $19.3M | 0.8% |
| 41 | CNCCENTENE CORP DEL | 300,000 | $19.3M | 0.8% |
| 42 | ERASERASCA INC | 1.0M | $18.3M | 0.7% |
| 43 | LLYELI LILLY & CO | 15,000 | $18.0M | 0.7% |
| 44 | ARWRARROWHEAD PHARMACEUTICALS IN | 200,000 | $16.3M | 0.6% |
| 45 | NVSTENVISTA HOLDINGS CORPORATION | 600,000 | $15.8M | 0.6% |
| 46 | MEDTRONIC PLC | 200,000 | $15.6M | 0.6% |
| 47 | WATWATERS CORP | 40,000 | $15.0M | 0.6% |
| 48 | LIVANOVA PLC | 180,000 | $14.8M | 0.6% |
| 49 | NVONOVO-NORDISK A SCALL | 300,000 | $14.4M | 0.6% |
| 50 | FBRXFORTE BIOSCIENCES INC | 675,000 | $14.3M | 0.6% |
| 51 | MDGLMADRIGAL PHARMACEUTICALS INC | 25,000 | $13.4M | 0.5% |
| 52 | PRAXPRAXIS PRECISION MEDICINES I | 40,000 | $13.4M | 0.5% |
| 53 | ANROALTO NEUROSCIENCE INC | 500,000 | $13.2M | 0.5% |
| 54 | MLYSMINERALYS THERAPEUTICS INC | 450,000 | $12.1M | 0.5% |
| 55 | XENEXENON PHARMACEUTICALS INC | 200,000 | $12.1M | 0.5% |
| 56 | ASCENDIS PHARMA A/S | 45,000 | $12.0M | 0.5% |
| 57 | ACHCACADIA HEALTHCARE COMPANY IN | 400,000 | $11.8M | 0.5% |
| 58 | IRTCIRHYTHM HOLDINGS INC | 90,000 | $10.7M | 0.4% |
| 59 | BIOHAVEN LTD | 700,000 | $10.4M | 0.4% |
| 60 | BEAMBEAM THERAPEUTICS INC | 300,000 | $10.3M | 0.4% |
| 61 | IARTINTEGRA LIFESCIENCES HLDGS C | 550,000 | $9.9M | 0.4% |
| 62 | GEHCGE HEALTHCARE TECHNOLOGIES I | 150,000 | $9.6M | 0.4% |
| 63 | RGNXREGENXBIO INC | 800,000 | $9.6M | 0.4% |
| 64 | ABSIABSCI CORPORATION | 800,000 | $9.3M | 0.4% |
| 65 | BRKRBRUKER CORP | 150,000 | $9.0M | 0.4% |
| 66 | CORCENCORA INC | 30,000 | $8.5M | 0.3% |
| 67 | COGTCOGENT BIOSCIENCES INC | 200,000 | $7.7M | 0.3% |
| 68 | ELVNENLIVEN THERAPEUTICS INC | 150,000 | $7.6M | 0.3% |
| 69 | BIOABIOAGE LABS INC | 300,000 | $7.4M | 0.3% |
| 70 | JAZZ PHARMACEUTICALS PLC | 30,000 | $7.2M | 0.3% |
| 71 | SANASANA BIOTECHNOLOGY INC | 2.0M | $7.0M | 0.3% |
| 72 | IVAINVENTIVA SA | 1.5M | $5.7M | 0.2% |
| 73 | TARAPROTARA THERAPEUTICS INC | 1.5M | $5.7M | 0.2% |
| 74 | ALKERMES PLC | 100,000 | $5.2M | 0.2% |
| 75 | LBRXLB PHARMACEUTICALS INC | 150,000 | $4.9M | 0.2% |
| 76 | KARDKARDIGAN INC | 200,000 | $4.8M | 0.2% |
| 77 | BNTXBIONTECH SE | 50,000 | $4.7M | 0.2% |
| 78 | INSPINSPIRE MED SYS INC | 100,000 | $4.5M | 0.2% |
| 79 | TRVITREVI THERAPEUTICS INC | 200,000 | $3.7M | 0.1% |
| 80 | IDYAIDEAYA BIOSCIENCES INC | 100,000 | $3.7M | 0.1% |
| 81 | CLDXCELLDEX THERAPEUTICS INC NEW | 100,000 | $3.7M | 0.1% |
| 82 | SVRASAVARA INC | 600,000 | $3.7M | 0.1% |
| 83 | RLMDRELMADA THERAPEUTICS INC | 500,000 | $3.5M | 0.1% |
| 84 | MOBIMOBIA MED INC | 250,000 | $3.4M | 0.1% |
| 85 | SIONSIONNA THERAPEUTICS INC | 75,000 | $3.3M | 0.1% |
| 86 | MANEVERADERMICS INC | 25,000 | $3.1M | 0.1% |
| 87 | IKTINHIBIKASE THERAPEUTICS INC | 1.4M | $2.7M | 0.1% |
| 88 | RZLTREZOLUTE INC | 500,000 | $2.6M | 0.1% |
| 89 | DNLIDENALI THERAPEUTICS INC | 100,000 | $2.6M | 0.1% |
| 90 | TENXTENAX THERAPEUTICS INC | 167,000 | $2.4M | 0.1% |
| 91 | OLMAOLEMA PHARMACEUTICALS INC | 100,000 | $1.3M | 0% |
| 92 | AURAAURA BIOSCIENCES INC | 170,000 | $1.2M | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.